Literature DB >> 20584171

Thromboangiitis obliterans and endothelial function.

Michel Azizi1, Pierre Boutouyrie, Alessandra Bura-Rivière, Séverine Peyrard, Stéphane Laurent, Jean-Noël Fiessinger.   

Abstract

BACKGROUND: Endothelial dysfunction may be involved in the pathophysiology of thromboangiitis obliterans (TAO). This study compares endothelial function and large artery stiffness between 10 TAO patients assessed during an exacerbation phase and 10 age- and sex-matched control subjects.
MATERIAL AND METHODS: Flow-mediated vasodilation after gradual hand skin heating (from 28 degrees C to 44 degrees C) and endothelium-independent vasodilation after sublingual administration of 150 microg glyceryl trinitrate (GTN) were studied using a high-resolution echotracking system to simultaneously measure the brachial artery (BA) diameter and changes in wall shear stress. Aortic stiffness was assessed by carotid-to-femoral pulse wave velocity.
RESULTS: The baseline BA diameter was significantly smaller in TAO patients (3599 +/- 668 microm) than in control subjects (4114 +/- 671, P = 0.04). Hand warming caused a linear increase in shear stress accompanied by a linear increase in BA diameter as a function of increasing temperature for TAO patients and control subjects. There was no significant difference between the two groups [relative increase in BA diameter: + 9.3% (-0.1 to 11.5) vs. + 4.8% (3.0 to 8.1), respectively; P = 0.63]. The slope of the BA diameter vs. shear stress relationship did not significantly differ between the two groups. The relative increase in the BA diameter after GTN was significantly greater in TAO patients than in controls [+ 30.8% (28.6 to 33.6) vs. + 16.2% (12.6 to 21.9) respectively; P = 0.02]. Finally, TAO patients had greater aortic stiffness than control subjects (9.81 +/- 1.72 m s(-1) vs. 7.82 +/- 0.84 m s(-1) respectively; P = 0.0052).
CONCLUSIONS: Acute TAO is characterised by vasoconstriction and increased aortic stiffness in the absence of changes in flow-mediated dilation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584171     DOI: 10.1111/j.1365-2362.2010.02294.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

Review 1.  Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature.

Authors:  Javier Narváez; Carmen García-Gómez; Lorenzo Álvarez; Pilar Santo; María Aparicio; María Pascual; Mercè López de Recalde; Helena Borrell; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 2.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Ignacio J Rivera-Chavarría; José D Brenes-Gutiérrez
Journal:  Ann Med Surg (Lond)       Date:  2016-03-29

3.  Endothelial dysfunction in patients with Buerger disease.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Yoshinori Inoue
Journal:  Vasc Health Risk Manag       Date:  2017-08-23

4.  Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans.

Authors:  Shifeng Wu; Xin Sun; Wei Wu; Dazhi Shi; Tao Jiang
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

5.  Cilostazol on the expression of ICAM-1, VCAM-1 and inflammatory factors in plasma in patients with thromboangiitis obliterans.

Authors:  Fuchen Song; Bo Ji; Ting Chen
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.